What Researchers Did
Researchers conducted a systematic review and meta-analysis of 28 randomized controlled trials to evaluate interventions for managing late gastrointestinal symptoms after pelvic radiotherapy.
What They Found
The review found that 4% formalin was superior to sucralfate for improving gastrointestinal symptom scores (standardised mean difference -1.07, 95% confidence interval -1.48 to -0.65), while argon plasma coagulation was inferior to sucralfate (standardised mean difference 1.22, 95% confidence interval 0.84 to 1.59). Counselling also positively influenced symptom scores (standardised mean difference -0.53, 95% confidence interval -0.76 to -0.29), but combining sucralfate with argon plasma coagulation increased moderate-severe bleeding markers compared to argon plasma coagulation alone (risk ratio 2.26, 95% confidence interval 1.12 to 4.55).
What This Means for Canadian Patients
Canadian patients experiencing late gastrointestinal symptoms after pelvic radiotherapy might benefit from interventions like 4% formalin or counselling, which showed positive effects on symptom scores. However, caution is advised with treatments like argon plasma coagulation, especially when combined with sucralfate, due to potential for increased bleeding.
Canadian Relevance
This study did not include Canadian participants or research sites, so direct Canadian relevance is not established.
Study Limitations
The conclusions are limited by small study sizes, varying methodological quality, and heterogeneity among the included trials.